TY - JOUR
T1 - Oxidative stress, protein modification and Alzheimer disease
AU - Tramutola, A.
AU - Lanzillotta, C.
AU - Perluigi, M.
AU - Butterfield, D. Allan
N1 - Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2017/7
Y1 - 2017/7
N2 - Alzheimer disease (AD) is a progressive neurodegenerative disease that affects the elderly population with complex etiology. Many hypotheses have been proposed to explain different causes of AD, but the exact mechanisms remain unclear. In this review, we focus attention on the oxidative-stress hypothesis of neurodegeneration and we discuss redox proteomics approaches to analyze post-mortem human brain from AD brain. Collectively, these studies have provided valuable insights into the molecular mechanisms involved both in the pathogenesis and progression of AD, demonstrating the impairment of numerous cellular processes such as energy production, cellular structure, signal transduction, synaptic function, mitochondrial function, cell cycle progression, and degradative systems. Each of these cellular functions normally contributes to maintain healthy neuronal homeostasis, so the deregulation of one or more of these functions could contribute to the pathology and clinical presentation of AD. In particular, we discuss the evidence demonstrating the oxidation/dysfunction of a number of enzymes specifically involved in energy metabolism that support the view that reduced glucose metabolism and loss of ATP are crucial events triggering neurodegeneration and progression of AD.
AB - Alzheimer disease (AD) is a progressive neurodegenerative disease that affects the elderly population with complex etiology. Many hypotheses have been proposed to explain different causes of AD, but the exact mechanisms remain unclear. In this review, we focus attention on the oxidative-stress hypothesis of neurodegeneration and we discuss redox proteomics approaches to analyze post-mortem human brain from AD brain. Collectively, these studies have provided valuable insights into the molecular mechanisms involved both in the pathogenesis and progression of AD, demonstrating the impairment of numerous cellular processes such as energy production, cellular structure, signal transduction, synaptic function, mitochondrial function, cell cycle progression, and degradative systems. Each of these cellular functions normally contributes to maintain healthy neuronal homeostasis, so the deregulation of one or more of these functions could contribute to the pathology and clinical presentation of AD. In particular, we discuss the evidence demonstrating the oxidation/dysfunction of a number of enzymes specifically involved in energy metabolism that support the view that reduced glucose metabolism and loss of ATP are crucial events triggering neurodegeneration and progression of AD.
KW - ATP synthase
KW - Alzheimer disease
KW - Glucose metabolism
KW - Oxidative stress
KW - Protein oxidation
UR - http://www.scopus.com/inward/record.url?scp=84981494654&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84981494654&partnerID=8YFLogxK
U2 - 10.1016/j.brainresbull.2016.06.005
DO - 10.1016/j.brainresbull.2016.06.005
M3 - Review article
C2 - 27316747
AN - SCOPUS:84981494654
SN - 0361-9230
VL - 133
SP - 88
EP - 96
JO - Brain Research Bulletin
JF - Brain Research Bulletin
ER -